Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CB | P42338 | 19/20 | 0.54 |
| ▸ | PIK3CD | O00329 | 14/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 12/20 | 0.53 |
| ▸ | PIK3CG | P48736 | 11/20 | 0.53 |
| ▸ | F10 | P00742 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16308425 | 0.94 | PIK3CB (0.58) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL16308427 | 0.92 | PIK3CB (0.57) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL15029914 | 0.91 | PIK3CB (0.56) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL16308429 | 0.90 | PIK3CB (0.54) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL16308540 | 0.90 | PIK3CB (0.57) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL16308521 | 0.90 | PIK3CB (0.54) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL16308528 | 0.90 | PIK3CB (0.54) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL16308467 | 0.89 | PIK3CB (0.60) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL15029471 | 0.88 | PIK3CB (0.53) | PIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL16308424 | 0.88 | PIK3CB (0.52) | PIK3CBPIK3CDPIK3CAPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8912180-B2 | Heterocyclic compound | ASTELLAS PHARMA INC. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-8912180-B2 | Heterocyclic compound | ASTELLAS PHARMA INC. (JP) | 2014-12-16 | — | — | US | disclosed |